Halaman 2 - Glioma Dokter Terbaik - TOP-67 dokter

Phd Viola Fox mengepalai Klinik Hematologi, Onkologi, dan Perawatan Paliatif di BKZ Solingen, dengan pengalaman spesialis lebih dari 15 tahun dalam perawatan glioma dan tumor lainnya.

• Berspesialisasi dalam kemoterapi, imunoterapi, dan terapi tertarget
• Berkualifikasi dalam genetika untuk meningkatkan pendekatan pengobatan yang dipersonalisasi
• Aktif dalam penelitian biologi molekuler untuk terapi kanker yang inovatif
• Menjadi anggota perkumpulan onkologi Jerman dan Amerika

Prof. Elke Jaeger telah melakukan 1.100+ perawatan glioma dan menempati peringkat di antara ahli onkologi top Jerman selama lebih dari 20 tahun.

• 38 tahun spesialisasi dalam onkologi dan hematologi
• Kepala Onkologi di Klinik Nordwest
• Diakui sebagai spesialis sarkoma terkemuka
• Terdaftar dalam peringkat ahli onkologi terbaik majalah Focus

Dr. Alemdar spesialis dalam Onkologi Medis dengan pelatihan ekstensif di Universitas Akdeniz – pemimpin dalam perawatan onkologi.

• Tersertifikasi dalam Onkologi Medis sejak 2018
• Pengalaman lebih dari 15 tahun di bidang onkologi
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Profesor Shlomi Constantini berspesialisasi dalam bedah glioma dan merupakan anggota pemenang penghargaan dari American Association of Neurological Surgeons.

• Melakukan prosedur bedah mikro dan neuro-endoskopi tingkat lanjut
• Menjalani pelatihan bedah tumor supratentorial dan infratentorial di Eropa
• Memegang penghargaan penelitian untuk studi tekanan otak dan penelitian klinis
• Menjadi anggota European Society of Pediatric Neurosurgery dan International Federation of Neuroendoscopy
• Mengobati tumor otak pada orang dewasa maupun anak-anak di Sourasky Medical Center

Seorang ahli bedah saraf terkemuka di dunia, Prof. Zvi Ram memimpin European Association of Neurosurgical Societies dan menyediakan perawatan glioma inovatif di Sourasky Medical Center.

• Ahli dalam bedah tumor otak kompleks dengan pemetaan otak dan stimulasi otak dalam
• Sangat terlatih dalam teknik bedah mikro dan panduan gambar untuk tumor otak
• Melakukan penelitian terkemuka tentang terapi berbasis gen untuk kanker otak
• Diakui dengan Goldhirsh Foundation Award untuk perawatan neurologi inovatif

Dr. Yildiz memiliki pengalaman spesialis onkologi selama lebih dari satu dekade, dengan fokus pada kasus kanker stadium lanjut di Medipol Mega University Hospital.

• Berpengalaman lebih dari 15 tahun di bidang onkologi medis
• Memegang gelar profesor di bidang onkologi – seorang ahli yang melatih dokter lain
• Telah mempublikasikan banyak karya di jurnal medis internasional tentang berbagai jenis kanker
• Anggota European Society for Medical Oncology (ESMO)
• Minat khusus pada tumor neuroendokrin dan penanganan kasus yang kompleks

Univ. Prof. Dr. Wolfgang Köstler adalah ahli terkemuka dalam pengobatan glioma, spesialis dalam terapi target dan pengobatan kanker individual di Wiener Privatklinik.

• Pengalaman lebih dari 20 tahun di bidang onkologi medis
• Fokus pada pengembangan biomarker dan biologi tumor
• Wakil Kepala Divisi Klinis Onkologi di Universitas Kedokteran Wina
• Dipublikasikan secara luas di jurnal internasional terkemuka

Spesialisasi dalam viroterapi – salah satu bidang imunologi terbaru – dengan pengalaman 30+ tahun di Klinik Pallas.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga
• Magang di Spesialis Penyakit Dalam

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Prof. Madya Nail Paksoy adalah seorang spesialis onkologi medis yang ahli dalam perawatan glioma di Rumah Sakit Medipol Bahçelievler, dengan sertifikasi Dewan ESMO dan pengalaman penelitian yang luas.

• Menyelesaikan pelatihan fellowship di Institut Onkologi Universitas Istanbul
• Berpartisipasi dalam 8 uji klinis internasional untuk pengobatan kanker
• Menerbitkan berbagai studi tentang tumor otak dan neuro-onkologi
• Tersertifikasi Dewan ESMO dalam Onkologi Medis

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Pelopor dalam menetapkan kriteria ketat untuk sindrom neurologis paraneoplastik – Dr. Graus adalah tokoh terkemuka dalam neuro-onkologi di Hospital Quiron Barcelona.

• Mantan Kepala Neurologi di Hospital Clinic, Barcelona
• Pendiri dan mantan presiden European Association of Neuro-Oncology
• Terlatih dalam neuro-onkologi di Memorial Sloan-Kettering Cancer Center
• Dianugerahi Doctor Honoris Causa oleh Lyon University